Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrizio Celesti

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Clinical Immunology (Orlando, Fla.)|June 18, 2026
Comparison between glioblastoma and brain metastases: How epigenetic remodeling can enhance immunotherapyFabrizio Celesti
IEEE Reviews in Biomedical Engineering|July 12, 2018
Why Deep Learning Is Changing the Way to Approach NGS Data Processing: A ReviewFabrizio Celesti, Antonio Celesti, Jiafu Wan, et al.
Cancers|November 3, 2020
Unveiling the Hidden Treasury: CIITA-Driven MHC Class II Expression in Tumor Cells to Dig up the Relevant Repertoire of Tumor Antigens for Optimal Stimulation of Tumor Specific CD4+ T Helper CellsGreta Forlani, Mariam Shallak, Fabrizio Celesti, et al.
Trends in Biotechnology|April 2, 2017
Are Next-Generation Sequencing Tools Ready for the Cloud?Antonio Celesti, Fabrizio Celesti, Maria Fazio, et al.
Frontiers in Immunology|March 30, 2023
Protective anti-tumor vaccination against glioblastoma expressing the MHC class II transactivator CIITAFabrizio Celesti, Andrea Gatta, Mariam Shallak, et al.
Frontiers in Immunology|July 22, 2024
Novel vaccination strategies based on optimal stimulation of CD4<sup>+</sup> T helper cells for the treatment of oral squamous cell carcinomaLorenzo Azzi, Fabrizio Celesti, Anna Maria Chiaravalli, et al.
Oncotargets and Therapy|September 16, 2025
The Immunomodulatory Activity of Thymosin Alpha 1 on Tumor Cell Lines and Distinct Immune Cell SubsetsLaura Solmonese, Maria Fortunata Lofiego, Carolina Fazio, et al.
International Journal of Molecular Sciences|September 28, 2023
Humoral and Cellular Immune Response Elicited by the BNT162b2 COVID-19 Vaccine Booster in ElderlyDaniela Dalla Gasperina, Giovanni Veronesi, Carlo M Castelletti, et al.
Journal of Translational Medicine|March 1, 2024
Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approachesMaria Fortunata Lofiego, Francesca Piazzini, Francesca Pia Caruso, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 19, 2025
DNA methylation status classifies pleural mesothelioma cells according to their immune profile: implication for precision epigenetic therapyMaria Fortunata Lofiego, Rossella Tufano, Emma Bello, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Clinical Immunology (Orlando, Fla.)|June 18, 2026
Comparison between glioblastoma and brain metastases: How epigenetic remodeling can enhance immunotherapyFabrizio Celesti
IEEE Reviews in Biomedical Engineering|July 12, 2018
Why Deep Learning Is Changing the Way to Approach NGS Data Processing: A ReviewFabrizio Celesti, Antonio Celesti, Jiafu Wan, et al.
Cancers|November 3, 2020
Unveiling the Hidden Treasury: CIITA-Driven MHC Class II Expression in Tumor Cells to Dig up the Relevant Repertoire of Tumor Antigens for Optimal Stimulation of Tumor Specific CD4+ T Helper CellsGreta Forlani, Mariam Shallak, Fabrizio Celesti, et al.
Trends in Biotechnology|April 2, 2017
Are Next-Generation Sequencing Tools Ready for the Cloud?Antonio Celesti, Fabrizio Celesti, Maria Fazio, et al.
Frontiers in Immunology|March 30, 2023
Protective anti-tumor vaccination against glioblastoma expressing the MHC class II transactivator CIITAFabrizio Celesti, Andrea Gatta, Mariam Shallak, et al.
Frontiers in Immunology|July 22, 2024
Novel vaccination strategies based on optimal stimulation of CD4<sup>+</sup> T helper cells for the treatment of oral squamous cell carcinomaLorenzo Azzi, Fabrizio Celesti, Anna Maria Chiaravalli, et al.
Oncotargets and Therapy|September 16, 2025
The Immunomodulatory Activity of Thymosin Alpha 1 on Tumor Cell Lines and Distinct Immune Cell SubsetsLaura Solmonese, Maria Fortunata Lofiego, Carolina Fazio, et al.
International Journal of Molecular Sciences|September 28, 2023
Humoral and Cellular Immune Response Elicited by the BNT162b2 COVID-19 Vaccine Booster in ElderlyDaniela Dalla Gasperina, Giovanni Veronesi, Carlo M Castelletti, et al.
Journal of Translational Medicine|March 1, 2024
Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approachesMaria Fortunata Lofiego, Francesca Piazzini, Francesca Pia Caruso, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 19, 2025
DNA methylation status classifies pleural mesothelioma cells according to their immune profile: implication for precision epigenetic therapyMaria Fortunata Lofiego, Rossella Tufano, Emma Bello, et al.
Pageof 1